Education and Training
- Fellow in Pulmonary Medicine, Medicine, University of Pennsylvania, 2001 - 2004
- Medical Resident, Medicine, University of Pennsylvania, 1998 - 2001
- M.D., University of Pennsylvania, 1998
van den Blink, B, Dillingh, MR, Ginns, LC, Morrison, LD, Moerland, M, Wijsenbeek, M, Trehu, EG, Bartholmai, BJ, and Burggraaf, J. "Recombinant human pentraxin-2 therapy in patients with idiopathic pulmonary fibrosis: safety, pharmacokinetics and exploratory efficacy." The European respiratory journal 47, no. 3 (March 2016): 889-897.
Andrade, JD, Schwarz, M, Collard, HR, Gentry-Bumpass, T, Colby, T, Lynch, D, Kaner, RJ, and IPFnet Investigators, . "The Idiopathic Pulmonary Fibrosis Clinical Research Network (IPFnet): diagnostic and adjudication processes." Chest 148, no. 4 (October 2015): 1034-1042.
Foster, MW, Morrison, LD, Todd, JL, Snyder, LD, Thompson, JW, Soderblom, EJ, Plonk, K, Weinhold, KJ, Townsend, R, Minnich, A, and Moseley, MA. "Quantitative proteomics of bronchoalveolar lavage fluid in idiopathic pulmonary fibrosis." Journal of Proteome Research 14, no. 2 (February 2015): 1238-1249.
Morrison, L. "Interstitial Lung Disease and Autoimmune Lung Diseases. An Issue of the Immunology and Allergy Clinics of North America." Annals of the American Thoracic Society 11, no. 7 (September 2014): 1168-1168.
Swigris, JJ, Streiner, DL, Brown, KK, Belkin, A, Green, KE, Wamboldt, FS, and IPFnet Investigators, . "Assessing exertional dyspnea in patients with idiopathic pulmonary fibrosis." Respiratory Medicine 108, no. 1 (January 2014): 181-188.
Collard, HR, Yow, E, Richeldi, L, Anstrom, KJ, Glazer, C, and IPFnet investigators, . "Suspected acute exacerbation of idiopathic pulmonary fibrosis as an outcome measure in clinical trials." Respiratory Research 14 (July 13, 2013): 73-null.
Raghu, G, Behr, J, Brown, KK, Egan, JJ, Kawut, SM, Flaherty, KR, Martinez, FJ, Nathan, SD, Wells, AU, Collard, HR, Costabel, U, Richeldi, L, de Andrade, J, Khalil, N, Morrison, LD, Lederer, DJ, Shao, L, Li, X, Pedersen, PS, Montgomery, AB, Chien, JW, O'Riordan, TG, and ARTEMIS-IPF Investigators*, . "Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial." Annals of Internal Medicine 158, no. 9 (May 2013): 641-649.
Meltzer, EB, Barry, WT, D'Amico, TA, Davis, RD, Lin, SS, Onaitis, MW, Morrison, LD, Sporn, TA, Steele, MP, and Noble, PW. "Bayesian probit regression model for the diagnosis of pulmonary fibrosis: proof-of-principle." Bmc Medical Genomics 4 (October 5, 2011): 70-null.
Idiopathic Pulmonary Fibrosis Clinical Research Network, , Zisman, DA, Schwarz, M, Anstrom, KJ, Collard, HR, Flaherty, KR, and Hunninghake, GW. "A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis." The New England Journal of Medicine 363, no. 7 (August 2010): 620-628.
Stevens, PA, Pettenazzo, A, Brasch, F, Mulugeta, S, Baritussio, A, Ochs, M, Morrison, L, Russo, SJ, and Beers, MF. "Nonspecific interstitial pneumonia, alveolar proteinosis, and abnormal proprotein trafficking resulting from a spontaneous mutation in the surfactant protein C gene." Pediatric Research 57, no. 1 (2005): 89-98.